Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Tekcapital Plc | LSE:TEK | London | Ordinary Share | GB00BKXGY798 | ORD �0.004 |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 8.15 | 836,993 | 09:23:44 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 8.00 | 8.30 | 8.25 | 8.08 | 8.15 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Computer Programming Service | USD 735k | USD -15.69M | USD -0.0792 | -1.03 | 16.15M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 11:22:43 | O | 2,702 | 8.00 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 20/11/2024 | 16:26 | UK RNS | Tekcapital plc Notification of Major Holdings |
| 20/11/2024 | 07:00 | UK RNS | GenIP PLC Corporate Update |
| 15/11/2024 | 12:07 | ALNC |  Tekcapital fundraises USD1 million; notes investee revenue growth |
| 15/11/2024 | 07:00 | UK RNS | Tekcapital plc Fundraising of £1.0 Million |
| 13/11/2024 | 14:57 | UK RNS | Tekcapital plc Innovative Eyewear Inc. Q3 2024 Financial Results |
| 06/11/2024 | 07:00 | UK RNS | Tekcapital plc Portfolio Company Update Innovative Eyewear Inc |
| 30/10/2024 | 07:00 | UK RNS | Tekcapital plc Portfolio Company Update -Innovative Eyewear |
| 30/10/2024 | 07:00 | UK RNS | MicroSalt PLC New and Follow-on B2B Customer Orders |
| 08/10/2024 | 06:00 | UK RNS | GenIP PLC Corporate Update |
| 02/10/2024 | 09:10 | ALNC | TOP NEWS: Tekcapital investee GenIP starts trading on AIM |
Tekcapital (TEK) Share Charts1 Year Tekcapital Chart |
|
1 Month Tekcapital Chart |
Intraday Tekcapital Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 20/11/2024 | 07:22 | TEK - TekCapital: Profit from University Intellectual Property | 5,627 |
| 26/4/2020 | 06:38 | Tekcapital at the UK Investor Show | 1 |
| 25/6/2019 | 06:40 | Tekcapital...healthy salt ! | 7 |
| 26/11/2007 | 15:48 | Teck-Cominco: strong mgmt, a spread of commodities | 2 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 11:22:44 | 8.00 | 2,702 | 216.16 | O |
| 11:05:32 | 8.01 | 20,000 | 1,601.80 | O |
| 11:00:16 | 7.84 | 63,875 | 5,007.80 | UT |
| 09:46:17 | 8.30 | 100,000 | 8,300.00 | O |
| 09:45:56 | 8.03 | 125,000 | 10,037.50 | O |
| Top Posts |
|---|
Posted at 21/11/2024 08:20 by Tekcapital Daily Update Tekcapital Plc is listed in the Computer Programming Service sector of the London Stock Exchange with ticker TEK. The last closing price for Tekcapital was 8.15p.Tekcapital currently has 198,188,162 shares in issue. The market capitalisation of Tekcapital is £16,152,335. Tekcapital has a price to earnings ratio (PE ratio) of -1.03. This morning TEK shares opened at 8.15p |
Posted at 05/11/2024 19:27 by buywell3 Mr Gross----- What about the value of Innovative Eyewear Series 'A' Warrants ? ------ The CEO of Tekcapital has recently stated in a Tekcapital portfolio update: Tekcapital owns 100% of the shares of Lucyd Ltd, valued at US$2.6m as of 30 June 2024. Lucyd Ltd owns approximately 19% of shares in Innovative Eyewear, Inc. Innovative Eyewear Inc (“Lucyd” • Announced a new partnership with Windsor Eyes, a leading eyewear manufacturing and distribution firm. Over the last 50 years, Windsor has become a leading manufacturer and supplier of fashion eyewear under the Bruno Magli, Sanctuary, Pier Martino, Adolfo, Eyecroxx, as well as private label options • Announced a partnership with New Look Vision Group to distribute its smart eyewear in Canada. New Look Vision Group is one of the largest optical groups in Canada and has been rapidly expanding in the United States. • Production planning and preparation for launches of its licensed branded smart eyewear products: Nautica, Eddie Bauer and Reebok. • Appointed Micah Richards as a brand ambassador. Micah is a former Olympic athlete and English footballer, turned successful broadcaster. He is currently working for Sky Sports, CBS Sports and BBC Sport whilst he is also a co-host of "The Rest is Football" - a top ten UK podcast. Tekcapital owns 100% of the shares of Lucyd Ltd, valued at US$2.6m as of 30 June 2024. Lucyd Ltd owns approximately 19% of shares in Innovative Eyewear, Inc. -------------------- But Mr Gross what about the Series A Warrants attached to these 259,455 shares in Innovative Eyewear ? They have a value also do they not ? As recently has been shown when Lucyd sold 126,699 series 'A' warrants , issued at $21 each for a reduced price of $5 These series 'A' warrants were issued based upon 2 warrants per common stock share in the original IPO Hence Lucyd would have owned 519,910 such series 'A' warrants (ie 2 times 259,455) BUT have since sold 126,699 of them leaving Lucyd ( and hence Tekcapital as they own 100% of Lucyd ) still owning 393,211 series 'A' warrants Surely Mr Gross there should be a value of at least $5 a warrant for these which should be included in a valuation of the holding of Tekcapital ? -------------------- The rationale being that any company now seeking to acquire Innovative Eyewear would have to also buy any issued warrants Certain investors have acquired warrants from other 3rd parties for above market prices as there are limited innovative eyewear shares in issue. So Mr Gross could you please include such warrants on your next valuation as they clearly are now in demand buywell dyor PS MIAMI, Sept. 3, 2024 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (Nasdaq: LUCY), the developer of smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, today announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase an aggregate of 126,699 shares of the Company's common stock originally issued by the Company on June 26, 2023, each having an original exercise price of $21.00 per share, at a reduced exercise price of $5.00 per share. The closing of the warrant exercise transaction is expected to occur on or about September 4, 2024, subject to satisfaction of customary closing conditions. |
Posted at 05/11/2024 12:23 by 888icb When Simon Thompson valued TEK on 31st October:“ spot net asset value (NAV) is around $65.2mn (25.3p), or almost three times the company’s current share price. The 32 per cent rally in Tekcapital’s share price since I highlighted the valuation anomaly (‘IPOs set to drive a rerating of an unloved investment company’, 25 September 2024) has much further to run to narrow the 63 per cent share price discount to NAV. Buy.” When he did that valuation SALT was 77p whereas today it’s 92p so it’s a few million dollars light. Its also worth remembering what he said about Guident, which unlike the other investments has not yet been listed: “ Furthermore, there is scope to unlock the value in Tekcapital’s largest investment, an $18.1mn (6.8p) equity holding in Guident, a developer of remote monitoring and control software (RMCS) that improves the safety of autonomous vehicles and delivery robots. Tekcapital holds $4.3mn (1.6p) of CLNs in the company, too. The directors are in the process of seeking a private investment round ahead of a likely IPO, another share price catalyst and one that’s not in the price.” I think Guident is becoming a leading player in an industry that has massive growth potential and will turn out to be the jewel in TEK’s crown. |
Posted at 03/10/2024 18:07 by 888icb IC article valuation tableTekcapital's portfolio fair value estimate Portfolio company Carrying value 30 June 2024 Estimated carrying value on 25 September 2024 Value per share Guident $18.1mn $18.1mn 6.8p Innovative Eyewear $2.6mn $2.6mn 1.0p MicroSalt $38.9mn $22.8mn 8.6p Belluscura $2.2mn $1.4mn 0.5p GenIP $0.2mn $0.2mn 0.1p Smart Food Tek $0.0mn $0.0mn 0.0p Guident convertible loan notes $4.3mn $4.3mn 1.6p TekEurope $1.2mn $1.2mn 0.5p MicroSalt convertible loan notes $2.0mn $2.0mn 0.8p Portfolio fair value $69.5mn $52.6mn 19.8p Cash $0.3mn $0.3mn 0.1p Total NAV $69.8mn $52.9mn 19.9p It doesn’t copy toowell but you should be able to work it out such that although the value of the portfolio has fallen from $69.8 million in June to $52.9 million on 24th September due to the fall in SALTs share price the NAV per share is 19.8p compared to todays closing price of 6.1p. The final part of the article: “ Shareholders in Tekcapital should note that portfolio company GenIP (GNIP:39p) raised £1.75mn in an IPO on London’s junior market on 2 October 2024. The company provides generative artificial intelligence (GenAI) analytic services to help companies, research institutions and venture funds assess and commercialise new discoveries. GenIP combines expert human technical review with GenAI algorithms to provide insightful and verified services. The holding in GenIP had a £0.2mn carrying value in Tekcapital’s interim accounts, but the company’s retained 62.8 per cent stake post IPO is worth £4.3mn (2.15p), which boosts Tekcapital’s spot NAV to 22p a share. On this basis, the investment company’s share price is trading two-thirds below book value. Poor sentiment towards micro-cap companies and Aim companies explain part of the discount, as highlighted by the 29 per cent reversal in the FTSE All-Share Total Return index since I included Tekcapital’s shares in my 2022 Bargain Shares Portfolio. However, the level of risk aversion is extreme and completely ignores the multiple short-term catalysts that could narrow the share price discount to NAV. Recovery BUY” |
Posted at 03/10/2024 17:56 by 888icb Article in IC today does not agree with your doom and gloom viewpoints:“ IPOs set to drive a rerating of an unloved investment company Spin-offs of an AI analytic services company and a developer of software that improves the safety of autonomous vehicles could drive a material re-rating Says Simon Thompson. Further extracts: “ MicroSalt’s shares listed at 43p in an IPO earlier this year and the price doubled to 92.5p at the half-year-end. The holding accounted for 55 per cent of Tekcapital’s NAV of $69.8mn in the company’s interim results. Although MicroSalt’s share price has subsequently succumbed to profit-taking, the equity stake is still worth $22.8mn (8.6p) and accounts for 43 per cent of my spot net asset value (NAV) estimate of $52.9mn (19.9p). Tekcapital also holds $2mn (0.8p) of convertible loan notes (CLNs) that are very conservatively valued in its accounts.” “ So, with Tekcapital’s 69 per cent stake in MicroSalt and the CLNs cumulatively worth 34 per cent more than the investment company’s market capitalisation of £14mn, you are effectively getting a free ride on the rest of the investment portfolio, which has a valuation of $28.1mn (10.5p).” “ Free ride on multiple investments The largest investment is a $18.1mn (6.8p) equity holding in Guident, a developer of remote monitoring and control software (RMCS) that improves the safety of autonomous vehicles and delivery robots. Tekcapital holds $4.3mn (1.6p) of CLNs in the company, too. Guident has constructed a state-of-the-art RMCS centre in Boca Raton, the largest office complex in Florida and a premier technology and life sciences hub. It has also incorporated the technology into AuVe autonomous shuttles and entered a strategic partnership with Star Robotics, a leading Spanish security robotics company. The plan is to integrate Guident's teleoperation solution into Star Robotics' products and provide an autonomous security surveillance solution with a human-in-the-loop capability. To date, Tekcapital has funded investment in Guident from its own balance sheet. However, with market conditions improving, the directors now see the opportunity to crystalise the material balance sheet value held in Guident by seeking a private investment round ahead of a likely IPO. Guident has been investing in the fabrication and testing of regenerative shock absorbers for prospective clients in the automotive industry. It has a proof of concept agreement in place with an undisclosed tier-1 tyre manufacturer for the patented technology.” |
Posted at 20/9/2024 08:15 by buywell3 Innovative Eyewear (LUCY on NASDAQ) and Innovative Eyewear Warrants (LUCYW on NASDAQ)Both of these are now up circa 100% this week Innovative Eyewear, Inc. Announces Closing of Exercise of Warrants Innovative Eyewear, Inc. Sept 4th 2024 Raises approximately $8 million since the beginning of the second quarter of 2024 MIAMI, Sept. 4, 2024 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (Nasdaq: LUCY), the developer of smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, announced today that it closed its previously announced transaction involving the exercise of certain outstanding warrants to purchase an aggregate of 126,699 shares of the Company's common stock originally issued by the Company on June 26, 2023, each having an original exercise price of $21.00 per share, at a reduced exercise price of $5.00 per share. H.C. Wainwright & Co. acted as the exclusive placement agent for the offering. The shares of common stock issued upon exercise of the warrants are registered pursuant to an effective registration statement on Form S-1 (File No. 333-272737). The gross proceeds to the Company from the exercise of the warrants were approximately $633,495, prior to deducting placement agent fees and offering expenses. Including the gross proceeds from this offering, the Company has raised approximately $8 million in gross proceeds since the beginning of the second quarter of 2024. Chief Executive Officer, Harrison Gross, commented: "the net proceeds from the financings in the last few months have greatly strengthened the Company's balance sheets. We intend to utilize these net proceeds for our upcoming Armor Smart Safety Glasses product line, expected to launch in the fourth quarter of 2024, Reebok ChatGPT-enabled sports glasses, expected to launch in the first quarter of 2025, marketing of Lucyd, Nautica and Eddie Bauer branded products on Amazon, BestBuy.com, and Target.com and for working capital and general corporate purposes." In consideration for the immediate exercise of the warrants for cash, the Company issued new unregistered Series A warrants to purchase up to an aggregate of 126,699 shares of common stock and new unregistered Series B warrants to purchase up to an aggregate of 126,699 shares of common stock. The new Series A and Series B warrants have an exercise price of $5.00 per share. The new Series A warrants are exercisable immediately and will expire five and one-half years from the date of issuance and the new Series B warrants are exercisable immediately and will expire eighteen months from the date of issuance. The new warrants described above were offered in a private placement and, along with the shares of common stock issuable upon exercise of the new warrants, have not been registered under the Securities Act of 1933, as amended (the "1933 Act"), or applicable state securities laws. Accordingly, the new warrants and shares of common stock issuable upon the exercise of the new warrants may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the 1933 Act and such applicable state securities laws. Seems IMO that Innovative Eyewear is starting to attract interest What are Tekcapital Warrant holdings now ? and with the LUCY share price near to $10 , could Tekcapital consider adding warrants as 80 cents each dyor |
Posted at 14/9/2024 16:30 by jaknife 888ICB,"Don’t forget Guidant which has great technology in markets that have massive growth potential. Guidant could well be the jewel in the crown that transforms TEK’s cash situation when it IPO’s." Guidant is a pile of poo. The only reason that you might think otherwise is: A. TEK Capital have done a skanky revaluation of the underlying assets. In 2018 TEK invested a mere $23.5k into Guident Limited, they then did a skanky deal to revalue Guident such that, at year-end, they could claim to shareholders that Guident was worth $8.5m! Since then TEK have performed other transactions such that they can revalue the shares and claim that they are worth a large number. B. TEK Capital have made wildly promotional claims about Guident. This follows a pattern of behaviour that TEK Capital have displayed over numerous years. First it was Lucyd that was launched to a fanfayre that then flopped, then it was Belluscura where a culture of making wildly optimistic sales was created - it too has flopped. Number three was Microsalt where , yet again, expectations of greatness have been created and yet the reality is proving to be much plainer. Microsalt's interims results are due later this month and they will show trivial revenues, material losses and a super weak balance sheet. The share price since IPO has begun the same downward trend that has occurred with both Lucyd and Belluscura! Anyone who believes that Guident is a hugely successful business, after seeing TEK Capital's track record of hopelessly wild over-promotional claims for its previous three investments, is nought but a fool. The reality with Guident is that it's a pre-revenue business that's burning cash whilst trying to compete with Tech giants who have significantly deeper pockets. It will require material amounts of additional investment before it's even at a revenue generating stage. And the reality with TEK Capital is that its product is dreams - it sells dreams to its retail shareholder base and they lap them up every time, over-paying for shares of the poor companies that it floats. JakNife |
Posted at 15/5/2024 15:16 by davebowler The Oakbloke saysCan Lucyd Armor save us? Dear reader, In FY23 Lucy results I wrote Nasdaq-listed LUCY needs 80% Quarter to Quarter growth in revenue and improvement in margin. Net revenue for the quarter ended March 31, 2024 was $383,471, which was an increase of 165% from the quarter ended March 31, 2023. That sounds impressive. Various share news services are proudly broadcasting this. LUCY shares were up 22% at one point today. This year-over-year increase was primarily attributable to significant volume growth in the e-commerce channel, driven by the Company's strategic advertising and marketing initiatives during the latter portion of 2023 and through the current quarter, combined with recent new product launches (including the Lyte XL and Nautica® Powered by Lucyd collections). Wonderful. But not so fast. Quarter to Quarter the picture is far less rosy. $559,759 revenue falls to $383,471 vs my own estimates where an 80% growth to $1m in Q1 would put this on a path to profitability. We are miles away from any such outcome. On a more positive note, Quarter to Quarter gross profitability increases $187k (to a positive but paltry $6,951 gross profit). The commentary points to discounting due to competitive pressures but analysis shows the prescription lenses generated that $7k profit while non-prescription actually lost money. No one else sells prescription smart glasses so what discount? It’s not at all clear. Sales falling from 34% to just 4% of sales via reseller partners suggests the strategy of “small independent retailers” has comprehensively failed. LUCY speak to switching to larger retailers but say this will take time. A very disappointing development. The Blueshift Premium lenses whilst providing a form of differentiation also appears to be an explanation of the high cost of sales of non prescription glasses. Why add this feature and sell it at a loss? It is frustrating to see this has detracted from progress towards break even. The lack of commercial control is disappointing. LUCY management speak to realising some economies of scale in the cost of frames and in the area of shipping and logistics. However they (confusingly) blame the growth in prescription costs impacting gross margin too. If you compare revenue and cost of sales for prescription and non-prescription then this is completely contradictory. LUCY say they are working with the current prescription lens provider to explore opportunities to reduce costs and we are also actively in discussions with alternative prescription lens suppliers who may help further lower lens fulfillment costs. It’s not clear why the costs have grown so much and why was there no price agreement in place? It sounds like a lack of commercial control - allowing the supplier to increase prices - have LUCY been taken for a ride? The long-term goal of shifting the sales mix over time more towards the wholesale channel, which carries higher margins, LUCY claim as such sales to our third-party retail store partners do not include the cost of prescription lenses. Wholesale should never carry higher margins than selling retail (direct) to the end user. Another contradiction to contend with. Future Outlook Three new product lines - Eddie Bauer® Reebok® and the Lucyd Armor smart safety glasses line (Previously Lion) are due to launch in 2024. Meanwhile plans to launch new features for the Lucyd app in 2024, including a paid "Pro" version of the app, could provide another potential incremental revenue stream for the Company too. Harrison Gross, CEO of Innovative Eyewear Inc., commented, "After several years of rigorous R&D and brand development, I believe we are very well-positioned to capitalize on blooming consumer interest in smart eyewear. Recently, we have seen powerful incumbents such as Apple and Meta bringing renewed interest to smart glasses. We continue to expect that smart eyewear will be a key component of the generative AI revolution, due to their transparent interfaces and ergonomic form factors perfectly suited for voice-based interaction." Tekcapital owns 5.2 million shares in Innovative Eyewear which is ~40% of the total issued share capital of LUCY. LUCY’s share price has dropped $0.29 to $0.20 since my Q4 update. Ouch. At today’s market price of $0.20 that ownership is worth $1m/£0.8m or 0.4p/TEK share (TEK is £17.2m market cap total at today’s 9p ask). Because TEK has a controlling interest there’s a 15% mark up on the NAV so 0.46p/TEK share. Conclusion 1Q24 is a disappointment. Those Investor publications who’ve regurgitated the 165% Revenue Increase year on year “news” have missed the point. You might as well boast that Smart Eyewear sales have increased since the Victorian times also. The hope now is that Q2 addresses not only the cost of sale challenge but also the sales growth challenge simultaneously. As well as progress the launch of three new brands including one for a completely new type of glasses to a completely new type of customer (B2B Industrial) whereas 100% of marketing has been to B2C fashion and tech savvy consumers. The Armor glasses aren’t a bad idea but are also a huge distraction in a new direction. $1.02m has been raised post period; but this provides about 2 months additional runway based on current cash burn. I have finally run out of patience with this holding and am writing it off to zero in my analysis, pending a tremendous turn around in Q2 which I am now sceptical can and will arrive. For UK investors who hold LUCY as part of TEK, writing off 0.4p per TEK share is actually less than increases at other TEK holdings, for example SALT has increased by 1.1p per TEK share (i.e. 95p/97p bid ask today) in the past 2 weeks. A NAV of 23.6p excluding LUCY versus a 9p ask is a 62% discount where 154% of the TEK price is covered by the value of LISTED holdings (or 188% if we still include LUCY). Thanks for reading The Oak Bloke’s Substack! Subscribe for free to receive new posts and support my work. Pledge your support Regards The Oak Bloke Disclaimers: This is not advice Micro cap and Nano cap holdings might have a higher risk and higher volatility than companies that are traditionally defined as "blue chip". The Oak Bloke’s Substack is free today. But if you enjoyed this post, you can tell The Oak Bloke’s Substack that their writing is valuable by pledging a future subscription. You won't be charged, unless they enable payments, and you decide to continue with a subscription. |
Posted at 15/5/2024 08:25 by backmarker Fair enough that TEK can't capitalise on its SALT holding for some time - 9 months is it ? - but it sometimes seems that movement in the SALT share price is only grudgingly reflected in the TEK share price It will be interesting to see if the gap narrows over time. |
Posted at 19/2/2024 12:26 by retirementfund Given that TEK share price is currently less than 50% of NAV and it appears that companies are clearly performing in a positive manner V NAV.Having said that its not just about NAV for me Guident and Revive I suspect are worth significantly about current NAV but then if you look forward as to what they are going to be valued at the potential is truly staggering. We saw negative comments at 6.5p I am sure we will see the same at much higher values than this each to their own in my view |
Posted at 16/2/2024 08:14 by cheshire Latest from the Oak Bloke- love the £1.46 target. :)TEK:Runnning my value model and plugging in the latest share prices for BELL, LUCY and SALT I see TEK's NAV remains at a 46.4% discount to market cap - even after a 130% YTD rise.How on earth you might ask? Well, the recent IPO from SALT has a lot to do with that. But the newsflow hasn't changed (much) from what I covered over the past months. SALT's chair gave a great presentation and SALT's CFO and CEO presented well with updates that several UK supermarkets are in discussions, but the fact and market potential of SALT is no different than pre-prospectus. It heartens me that TEK is making progress even when market sentiment is adverse. It proves that stock market eventually is a weighing machine, and if you have a conviction then do not panic and sell. Recurring 30 tonne orders of Microsalt from a global food business (cough Pepsi), and US supermarket stockists far larger than Sainsburys (CVS has 8,500 vs Sainsbury has 1,500) got weighed eventually.But interesting to note, too, that you can STILL buy SALT by buying TEK (who own a large chunk of SALT) at a discount. A very decent 16.66% discount.Not forgetting that it's a 16.66% discount plus you get 91% of Guident, 7% of BELL, 40% LUCY and 100% of ReVive all for free.Why free? Well 15p covers just 83% of the value of the Microsalt shares since TEK own 76% of SALT.I see no reason other than it has not been IPO'd why Guident is worth any less than SALT. I set out the known newsflow for Guident in this article. There are millions of lives lost each year to excess of salt, but one day soon billions of robots and drones needing guiden(t)ce. Even before science fiction becomes fact, Autonomous Vehicles (AVs) are already emerging rapidly for mass transit.Meanwhile for LUCY the addressable market size is $148bn and forecast to grow to $250bn by 2030. Deals with Nautica, Reebok and Eddie Bauer in 2024 make this an exciting pick despite the past poor performance while it got going. Their latest Q4 quarterly update is imminent and my last view on LUCY and my forecasts you can read in this article.Lucyd "are easily the best" is the conclusion in this video.ReVive meanwhile is a concept product which could further revolutionise transport range anxiety and particularly EVs, but PHEVs and HEVs too. Think about regenerative braking and how that has changed the world. It is now commonplace and in fact in 2024 you'd have to go really downmarket to find a car without regen braking or "start/stop" as it's commonly called. So what about generating power over the bumps in the road? ReVive claims a 5-10 mile range extension to an EV and is the sort of business which could be licenced to OEMs to draw in a revenue stream.Which leaves BELL, now funded, with an established market-leading pair of products for oxygen therapy which have been optimised to lower costs for higher margins, and an order book of 6,500 units and growing where they tick certain redemption codes which makes them attractive to equipment distributors to the point where BELL are the only game in town from some vendors.And that still leaves TEK's research business, and future forays as it perhaps looks to its 6th venture now three of its five businesses are listed.I have maintained a potential upside of £1.56 per share is possible over the next two years. TEK's share price, overall, would need to grow about 5.5 times to get there. That's because I see 5 businesses with USPs serving 5 enormous addressable markets.But another way to look at this is simply this.If BELL can return to its prior highwater price (£1.46 a share), if LUCY the same $7.50 a share, if ReVive can achieve 60% of the estimated $125m target value, if Guident were valued in an IPO and beyond in 2 years at 5X its NAV today, and if SALT tripled from here in the next 2 years to £2.85 a share, then you arrive at £1.55 per TEK share.Is it quite so impossible from that perspective? BELL has advanced far further than when it was at that previous high, and LUCY the same and is regularly being compared to - and in comparison videos beating global brands like Ray-Ban, Amazon and Bose. I guess for LUCY it depends whether you believe in the wisdom of crowds and the consumer, plus driving towards cash generation. ReVive is a unknown quantity but the increasing volumes of vehicles and tangibility of range anxiety isn't. Guident at 5X is no more fanciful than SALT at 5X (hint: SALT is half way there already). 5X could be far too low for a technology that puts humans in the loop in a rapidly arriving AI/Robotics world.How TEK could arrive at £1.56What if it doesn't? I am not saying it's guaranteed - it's an upside forecast. But at today's 15p a share, the risk/reward of TEK remains such that if even 1 out of the 5 succeed in a meaningful way the pay off could be several times today's share price. All five might succeed is my point.This is not adviceOakThanks for reading The Oak Bloke's Substack! Subscribe for free to receive new posts and support my work. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
